Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20111
20122
20153
20171
20201
20211
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center5
Seoul National University Hospital2
AbbVie1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Jin Hyoung Kang1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
YM BioSciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms14
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms2
Melanoma2
Pancreatic Neoplasms2
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1
Glioblastoma1
Head and Neck Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.